Double blind placebo controlled exposure to molds: exposure system and clinical results*

10.1111/j.1600-0668.2005.00351.x ◽

2005 ◽

Vol 15 (s10) ◽

pp. 73-80 ◽

Author(s):

H. W. Meyer ◽

K. A. Jensen ◽

K. F. Nielsen ◽

J. Kildeso ◽

S. Norn ◽

...

Keyword(s):

Clinical Results ◽

Double Blind ◽

Exposure System ◽

Double Blind Placebo ◽

Controlled Exposure

Download Full-text

A double-blind placebo-controlled trial of azithromycin as an adjunct to non-surgical treatment of periodontitis in adults: clinical results

Journal Of Clinical Periodontology ◽

10.1034/j.1600-051x.2002.290109.x ◽

2002 ◽

Vol 29 (1) ◽

pp. 54-61 ◽

Author(s):

S. R. Smith ◽

D. M. Foyle ◽

J. Daniels ◽

S. Joyston-Bechal ◽

F. C. Smales ◽

...

Keyword(s):

Surgical Treatment ◽

Controlled Trial ◽

Clinical Results ◽

Double Blind ◽

Double Blind Placebo ◽

Non Surgical Treatment

Download Full-text

Negative Clinical Results from a Randomised, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy of Two Doses of Immunologically Enhanced, Grass Subcutaneous Immunotherapy Despite Dose-Dependent Immunological Response

Clinical Drug Investigation ◽

10.1007/s40261-014-0216-z ◽

2014 ◽

Vol 34 (8) ◽

pp. 577-586 ◽

Author(s):

Jörg Kleine-Tebbe ◽

Mikkel Walmar ◽

Klaus Bitsch-Jensen ◽

Elke Decot ◽

Oliver Pfaar ◽

...

Keyword(s):

Controlled Trial ◽

Immunological Response ◽

Clinical Results ◽

Subcutaneous Immunotherapy ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial

Neurology ◽

10.1212/wnl.43.4.655 ◽

1993 ◽

Vol 43 (4) ◽

pp. 655-655 ◽

Cited By ~ 1711

Author(s):

Keyword(s):

Multiple Sclerosis ◽

Interferon Beta ◽

Controlled Trial ◽

Clinical Results ◽

Double Blind ◽

Double Blind Placebo ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

Final clinical results from SUNRISE: A phase III, randomized, double-blind, placebo-controlled multicenter trial of bavituximab plus docetaxel in patients with previously treated stage IIIb/IV nonsquamous non-small cell lung cancer

Annals of Oncology ◽

10.1093/annonc/mdx380.065 ◽

2017 ◽

Vol 28 ◽

pp. v487 ◽

Author(s):

R. Palmero ◽

P. Bidoli ◽

I.M. Bondarenko ◽

M. Boyer ◽

P. Germonpre ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Clinical Results ◽

Multicenter Trial ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Previously Treated

Download Full-text

Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial

Clinical & Experimental Allergy ◽

10.1046/j.1365-2222.1997.1220903.x ◽

1997 ◽

Vol 27 (8) ◽

pp. 860-867 ◽

Author(s):

V.A. VARNEY ◽

J. EDWARDS ◽

K. TABBAH ◽

H. BREWSTER ◽

G. MAVROLEON ◽

...

Keyword(s):

Clinical Efficacy ◽

Specific Immunotherapy ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Oral budenosid is highly effective in the treatment of collagenous colitis: A randomized, double-blind, placebo-controlled, multicenter trial

Gastroenterology ◽

10.1016/s0016-5085(01)80196-7 ◽

2001 ◽

Vol 120 (5) ◽

pp. A40-A40 ◽

Author(s):

S MIEHLKE ◽

P HEYMER ◽

T OCHSENKUEHN ◽

E BAESTLEIN ◽

G YARIAN ◽

...

Keyword(s):

Collagenous Colitis ◽

Multicenter Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Highly Effective

Download Full-text

A randomized double blind, placebo controlled trial of a Chinese herbal preparation (CH100) in chronic Hepatitis C

Gastroenterology ◽

10.1016/s0016-5085(01)81907-7 ◽

2001 ◽

Vol 120 (5) ◽

pp. A384-A384

Author(s):

L MOLLISON ◽

L TOTTEN ◽

C HOVELL ◽

K THAYNE ◽

C CONNELLY ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Controlled Trial ◽

Herbal Preparation ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Patients with non-cardiac chest pain (NCCP) recelving an empirical trial of high dose lansoprazole, demonstrate early symptom response. A double blind, placebo-controlled trial

Gastroenterology ◽

10.1016/s0016-5085(01)81101-x ◽

2001 ◽

Vol 120 (5) ◽

pp. A221-A221 ◽

Author(s):

R FASS ◽

G PULLIAM ◽

C HAYDEN

Keyword(s):

Controlled Trial ◽

High Dose ◽

Double Blind ◽

Early Symptom ◽

Double Blind Placebo ◽

Symptom Response

Download Full-text

Mo1540 THE EFFICACY AND SAFETY OF GCWB104 (FLOS LONICERA EXTRACT) IN FUNCTIONAL DYSPEPSIA: A SINGLE-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

Gastroenterology ◽

10.1016/s0016-5085(20)32906-1 ◽

2020 ◽

Vol 158 (6) ◽

pp. S-887-S-888

Author(s):

Nayoung Kim ◽

Yonghoon Choi ◽

Dong Ho Lee

Keyword(s):

Functional Dyspepsia ◽

Controlled Study ◽

Efficacy And Safety ◽

Single Center ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

40: Oral Ketoconazole for Prevention of Postoperative Penile Erection, a Prospective, Randomized, Double Blind, Placebo Controlled Trial

The Journal of Urology ◽

10.1016/s0022-5347(18)30305-7 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 14-15

Author(s):

Brian J. DeCastro ◽

Jack R. Walter ◽

Leah P. McMann ◽

Andrew C. Peterson

Keyword(s):

Penile Erection ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text